MoonLake Immunotherapeutics (MLTX)

Distributing

Strong institutional distribution: ownership decreased -4.59% quarter-over-quarter.

Data as of Q1 2026

Institutional Ownership

88.22%

QoQ Change

-4.59%

Total Value

$1.2T

Shares Outstanding

73.6M

Crowding AnalysisCrowded

Holders145of 5,944

Avg: 68

Uncrowded89th percentileCrowded

Institutional Activity

Buy/Sell Ratio1.33x

76th percentile

92 buying69 selling

+42

New

-25

Closed

+5.2M

Net shares

Holding Period Distribution

estimate

Median: 2 QAvg: 2.2 QHolders: 145

Ownership Concentration

Top 5: 50.4%Top 10: 63.4%

BVF INC/IL24.6%

Deep Track Capital,9.9%

Cormorant Asset Management,6.9%

JANUS HENDERSON GROUP5.3%

D. E. Shaw & Co.,3.7%

Others (140)49.6%

Loading crowding analysis...

Conviction-Weighted Ownership

Median weight: 0.97%Avg weight: 2.03%Max: 9.50%High conviction (>1%): 5

BVF INC/IL

Deep Track Capital,

Cormorant Asset Management,

JANUS HENDERSON GROUP

D. E. Shaw & Co.,

CITADEL ADVISORS

MPM BioImpact

Weiss Asset Management

Logos Global Management

Point72 Asset Management, L.P.

Loading conviction analysis...

Whale Moves Timeline (8 Quarters)

Biggest dollar-value position changes among top 10 holders

SOLDBVF INC/IL$70M3.8M shr

NEWMPM BioImpact$34M1.8M shr

BOUGHTDeep Track Capital$34M1.8M shr

NEWWeiss Asset Management$32M1.7M shr

NEWPoint72 Asset Management, L.P.$26M1.4M shr

NEWDeep Track Capital$61M4.6M shr

NEWD. E. Shaw & Co.$33M2.5M shr

BOUGHTCormorant Asset Management$31M2.4M shr

NEWCITADEL ADVISORS$30M2.3M shr

NEWJANUS HENDERSON GROUP$28M2.1M shr

Loading whale moves...

Institutional Trends (8 Quarters)

Loading ownership trends...

Institutional Holders

Loading top holders...